Prognostic value of N-terminal prohormone B-type natriuretic peptide modified by renal function in patients with acute heart failure
European Journal of Internal Medicine · 2025
DOI: 10.1016/j.ejim.2025.06.017 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Internal Medicine, 2025. Verfasst von Rui Zhu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical C…. Hauptthemen laut MEDLINE: Natriuretic Peptide, Brain, Heart Failure, Peptide Fragments, Glomerular Filtration Rate. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Chinese Academy of Medical Sciences & Peking Union Medical College Fuwai Hospital.
Themen: Herzinsuffizienz
Abstract (Originalsprache)
INTRODUCTION: It remains unclear whether renal function and follow-up duration impact the prognostic value of N-terminal prohormone B-type natriuretic peptide (NT-proBNP) in patients with heart failure (HF). METHODS: A nationwide prospective cohort study was conducted in 4907 adults hospitalized for acute HF, of whom 4766 were eligible for analysis. We used Cox regression to estimate the relative risks and Poisson regression to assess the absolute risks of adverse outcomes associated with NT-proBNP levels at admission. Effect modification by renal function was tested in both Cox and Poisson models. RESULTS: Over a median follow-up period of 4.6 years, patients with the middle and highest NT-proBNP tertiles had hazard ratios (HRs) (95 % CI) of 1.41 (1.24-1.59) and 2.15 (1.89-2.44) for all-cause mortality, 1.59 (1.37-1.85) and 2.35 (2.01-2.74) for cardiovascular mortality, respectively, compared to those with the lowest tertile. These associations diminished over time. The associations between NT-proBNP levels and the risks of mortality (P-for-interaction < 0.01) were modified by estimated glomerular filtration rate (eGFR) levels, remaining significant yet weaker in HF patients with eGFR
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nephrology, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, China.
- National Clinical Research Center for Cardiovascular Diseases, NHC Key Laboratory of Clinical Research for Cardiovascular Medications, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for…
- Department of Nephrology, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, China. Electronic address: caijfbj@fuwaihospit…
Förderung
- Chinese Academy of Medical Sciences & Peking Union Medical College Fuwai Hospital
Zitieren
APA
Zhu, R., Wang, Y., Liu, L., Liu, X., Chen, Z., Wei, Y., Lin, W., Zhang, L., He, G., & Cai, J. (2025). Prognostic value of N-terminal prohormone B-type natriuretic peptide modified by renal function in patients with acute heart failure. European Journal of Internal Medicine. https://doi.org/10.1016/j.ejim.2025.06.017
Vancouver
Zhu R, Wang Y, Liu L, Liu X, Chen Z, Wei Y, et al. Prognostic value of N-terminal prohormone B-type natriuretic peptide modified by renal function in patients with acute heart failure. European Journal of Internal Medicine. 2025. doi:10.1016/j.ejim.2025.06.017
BibTeX
@article{Zhu2025,
author = {Zhu, Rui and Wang, Yaoyao and Liu, Lili and Liu, Xuejiao and Chen, Zhanyuan and Wei, Yu and Lin, Weifeng and Zhang, Lihua and He, Guangda and Cai, Jianfang},
title = {Prognostic value of N-terminal prohormone B-type natriuretic peptide modified by renal function in patients with acute heart failure},
journal = {European Journal of Internal Medicine},
year = {2025},
doi = {10.1016/j.ejim.2025.06.017}
}
EUVIMED